Fig. 53.1
The menstrual cycle. The menstrual cycle begins day 1 with menses or menstrual bleeding (early follicular phase). In the follicular phase, levels of progesterone and estrogen are low. The mid-follicular phase involves endometrial proliferation and a slow rise in estrogen to the point of ovulation. The follicular phase ends with a burst of luteinizing hormone (LH) if ovulation occurs (about day 14), and the follicle is released from the ovary to begin the luteal phase. At the mid-luteal phase, progesterone is at its peak, and falls until the next cycle begins (about 27–30 days). If ovulation does not occur, there is no luteal phase, progesterone remains flat, and the next cycle may begin earlier than 25 days or later than 35 days [10]. (reprinted with permission from Elsevier Jan 11, 2014)
Nathaniel Kleitman and his colleagues (1937) [11] were the first to study human sleep, and their sample of 35 young adults included 11 women, primarily graduate students at the University of Chicago. They described each adult’s age, sex, history of smoking and alcohol consumption, and sleep habits, but no mention was made of women’s menstrual cycles. In 1966, Williams, Agnew, and Webb published the first report on polysomnography (PSG) sleep characteristics in women. In that study of 16 women, researchers made a point of not monitoring PSG during days of menstrual flow, but exact phase of their cycles were not reported. During menstrual flow, there may be uterine cramping and pain, but all gonadal hormones would be secreted at basal levels, and comparable to levels in men of the same age [12].
A few years later, Williams and colleagues (1974) [13] compiled PSG data in a book format organized by sex and decade of life. These researchers were the first to control for potential menstrual cycle effects by studying women of childbearing age only during their follicular phase. In the follicular phase, before ovulation, progesterone levels remain low. Sample sizes were small (ten women between 20 and 29 years old and ten women between 30 and 39 years old) and included only healthy females across the lifespan. The small samples of women between 40 and 49 years old and between 50 and 59 years old were likely in various stages of menopausal transition [13]. It was in these comparison studies that older women appeared to have more delta sleep (stages 3 and 4) than men of the same age [13].
Ernest Hartmann (1966) [14] was the first sleep researcher to study women’s sleep architecture as it changed during the menstrual cycle. As a psychiatrist, he saw mood disorders in female patients that appeared to fluctuate in severity by phase of the menstrual cycle. He focused on REM sleep and reported PSG findings from four young healthy women and three psychiatric inpatients. Six of these seven women complained of premenstrual symptoms and the seventh was taking hormone therapy and hence not ovulating. He noted differences in rapid eye movement (REM) sleep when the follicular (preovulation) phase was compared to the luteal (postovulation) phase. However, findings from this type of small sample were not particularly generalizable to the population of all young women, and his findings have not been replicated. In the next published study on women’s sleep, Ho (1972) [15] reported no changes in REM across three menstrual cycles in her sample of six healthy women. Three of the women in Ho’s study were taking oral contraceptives and had less delta sleep (stages 3 and 4) while the other three women had an increase in delta sleep from their follicular to luteal phase. Ho’s (1972) [15] report was published as an abstract and presented at a national sleep conference. More complete details of her dissertation research were also published [16].
Sleep Disorders Associated with the Menstrual Cycle
When published in 1979, the diagnostic classification of sleep and arousal disorders (DCSAD) included a category under excessive somnolence called, “periodic hypersomnia” or “menstrual associated” excessive daytime sleepiness. It was described as “well established” based on three citations ([17], p. 58, 80–81)). However, it was based on one case of a young adolescent with premenstrual hypersomnia [18]. In 1982, another case of periodic hypersomnia was reported involving a 21-year-old with hypersomnia, but her excessive sleepiness occurred during the follicular phase [19]. In an early comparison study of sleep architecture in healthy women at two phases of the menstrual cycle, there were no significant differences in sleep stages that would indicate risk for premenstrual hypersomnia [20].
In the past two decades, there have been some changes and additions to types of sleep disorders associated with the menstrual cycle. Most of these studies involve women with varying levels of premenstrual distress. More severe cases of premenstrual distress are likely to have an underlying mood disorder that may fluctuate on a monthly basis with hormonal fluctuations in phases of the menstrual cycle. In more recent carefully controlled studies of premenstrual dysphoria, researchers have found no particular alterations in sleep architecture when compared to healthy controls [21].
The Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) published by the American Psychiatric Association (APA) includes premenstrual dysphoric disorder (PMDD) and describes disturbed sleep as one of the many symptoms within this disorder [22]. The type of disturbed sleep is highlighted as subjective reports rather than objective PSG findings, and focuses on complaints about insomnia and increased awakenings during the premenstrual week, rather than hypersomnia. However, DSM-IV research criteria for PMDD diagnosis do not distinguish between insomnia and hypersomnia [22] and the next edition of the DSM, scheduled for publication in 2013, may further refine this disorder.
Today, there is a somewhat better understanding of how progesterone and other hormones affect women’s sleep. Whether studies involve natural changes in intrinsic levels of hormone over the menstrual cycle [20] or extrinsic sources of progestins contained in oral contraceptives or hormone replacement therapy, it is critical that sleep researchers attend to the type of hormone and how it is metabolized [23]. Current research on sleep disorders associated with the menstrual cycle continues to focus on premenstrual mood disorders, but women with polycystic ovaries are beginning to be studied in sleep research because this infertility syndrome includes higher testosterone levels, obesity, and sleep apnea [24].
Sleep Disorders Associated with Pregnancy and Postpartum
The earliest study of women’s sleep during the last weeks of pregnancy and first few days after labor and delivery began with Ismet Karacan and his colleagues in Florida, USA. These studies involved only a few women in the hospital setting and results began appearing in published abstracts in 1967 and 1968 [25]. Most notable during those early studies was the researchers’ careful control for the newborn’s influence on the mother’s sleep. Each mother’s nocturnal sleep was monitored with PSG during the first few postpartum nights while her newborn was kept in the nursery all night. Since those initial reports, researchers have conducted more carefully controlled laboratory PSG studies with larger samples [26, 27] or focused on the naturalistic setting of the home environment using ambulatory PSG monitoring [28, 29]. Studies of pregnant women using PSG were always limited by small sample sizes and were focused on how maternal sleep disordered breathing might affect the fetus [30] or how pregnancy sleep patterns might predict postpartum depression [25, 31].
Since the normal changes in sleep during pregnancy include primarily less total sleep time due to more discomfort and wake time after sleep onset, rather than substantial changes in sleep architecture, more recent studies have utilized wrist actigraphy measures to objectively describe changes in sleep across pregnancy and transition to motherhood. These newer studies address how infant feeding schedules or breastfeeding influence mother’s sleep [32–34] or symptoms of depression [35, 36], and how co-sleeping or bed sharing can influence maternal–infant sleep patterns and sudden infant death syndrome [37].
Sleep Disorders Associated with Menopause
Menopause is defined as the cessation of menstrual periods. Due to irregularities in menstrual cycle lengths during menopausal transition, menopause can only be confirmed after 12 consecutive months without a menstrual period. The mean age of natural menopause is about 50–51 years old, but the ovaries can continue to secrete estrogen in sufficient or insufficient amounts for about 5–8 years prior to the actual onset of menopause. As seen in Fig. 53.2, the perimenopausal transition is variable and occurs over an unpredictable number of years, with irregular menstrual cycles and hormonal fluctuations [38].
Fig. 53.2
Stages of reproduction and menopausal transition. The stages of women’s reproductive aging include reproduction, menopausal transition, and postmenopause. The duration of each stage is variable, but menopausal transition has an early and late phase with endocrine changes noted, particularly in high follicle stimulating hormone (FSH) levels due to the absence of ovarian estrogen. Menopause is defined as no menses for 12 months (FMP = final menstrual period) and occurs at about 50 years of age, on average. Vasomotor symptoms of hot flashes and night sweats are most likely to occur during late perimenopause and early postmenopause stage [38]. (Elsevier journal—reprinted with permission on January 11, 2014)